Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
156.8 USD | -0.89% | -6.08% | -12.82% |
Financials (USD)
Sales 2024 * | 638M | Sales 2025 * | 740M | Capitalization | 8.76B |
---|---|---|---|---|---|
Net income 2024 * | 45M | Net income 2025 * | 88M | EV / Sales 2024 * | 13.3 x |
Net cash position 2024 * | 284M | Net cash position 2025 * | 420M | EV / Sales 2025 * | 11.3 x |
P/E ratio 2024 * |
268
x | P/E ratio 2025 * |
105
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.44% |
Latest transcript on Repligen Corporation
1 day | -0.89% | ||
1 week | -6.08% | ||
Current month | -4.54% | ||
1 month | -5.90% | ||
3 months | -20.00% | ||
6 months | -0.10% | ||
Current year | -12.82% |
Managers | Title | Age | Since |
---|---|---|---|
Tony Hunt
CEO | Chief Executive Officer | 60 | 14-04-30 |
Olivier Loeillot
PSD | President | 54 | 23-10-01 |
Jason Garland
DFI | Director of Finance/CFO | 50 | 23-09-24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Karen Dawes
CHM | Chairman | 72 | 05-08-31 |
Director/Board Member | 58 | 14-06-11 | |
Martin Madaus
BRD | Director/Board Member | 64 | 23-02-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.43% | 5 M€ | -1.80% | - | |
1.01% | 0 M€ | 0.00% | - | |
0.84% | 0 M€ | 0.00% | - | |
0.55% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 156.8 | -0.89% | 726,710 |
24-05-24 | 158.2 | -0.39% | 362,382 |
24-05-23 | 158.8 | -3.85% | 430,157 |
24-05-22 | 165.1 | -1.06% | 456,614 |
24-05-21 | 166.9 | -2.84% | 358,952 |
Delayed Quote Nasdaq, May 28, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.82% | 8.76B | |
-7.38% | 177B | |
-0.46% | 108B | |
-6.98% | 65.55B | |
+2.65% | 50.66B | |
+5.27% | 42.58B | |
+5.73% | 40.74B | |
+19.92% | 31.07B | |
+16.57% | 25.45B | |
-7.00% | 23.85B |
- Stock Market
- Equities
- RGEN Stock